Delivery Order 36C26325D0022-36C26325N0347

Award Date 12/8/24
Potential Completion Date 9/30/25
Potential Value $140K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Fremont, CA 94538, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded to Microgenics Corporation, a subsidiary of Thermo Electron Corporation, by the Veterans Integrated Service Network 23. The contract is for the delivery of toxicology reagents, with a modification to add a line item to the base year and each option year. The contract has a ceiling value of $165,317.60 and a performance period ending on September 30, 2026. Microgenics Corporation is a for-profit manufacturer of clinical diagnostic products and...
This contract award is for TOXICOLOGY REAGENTS AND EQUIPMENT to Microgenics Corporation, a subsidiary of Thermo Electron Corporation, for a ceiling value of $60,404.41. The award is a Blanket Purchase Agreement (BPA) call from the Veterans Integrated Service Network 1 (VISN 1), a component of the Department of Veterans Affairs. Microgenics Corporation is a manufacturer of clinical diagnostic products and toxicology testing solutions. This contract supports the Department of Defense Drug Demand...
This federal contract award to Microgenics Corporation, a clinical diagnostics division of Thermo Electron Corporation, is for the supply of drugs of abuse analyzers, reagents, and controls. The $1,150.00 firm fixed-price delivery order was issued by the Veterans Integrated Service Network 23, a civilian agency, and has an ultimate completion date of December 7, 2024. Microgenics is an experienced supplier of immunoassay reagent test kits and related laboratory supplies for substance abuse...
This federal contract award was issued by the Veterans Integrated Service Network 23 (VISN 23), a civilian agency, to Microgenics Corporation, a for-profit manufacturer of diagnostic products. The $74,348.50 firm-fixed-price delivery order is for the supply of drugs of abuse analyzers, reagents, and controls. The contract is not set aside and is associated with a larger indefinite delivery contract (IDC) worth $852,120.80 that Microgenics holds with VISN 23 for toxicology reagents. Microgenics...
This federal contract award to Microgenics Corporation is a $8,134.80 firm-fixed price delivery order under existing indefinite delivery vehicles (IDVs) with the Department of Defense and Department of Veterans Affairs. The award is for the supply of DRI Opiate 500 ML Reagent Test Kits, which support substance abuse testing and treatment programs at military medical facilities and VA hospitals. Microgenics, a subsidiary of Thermo Electron Corporation, has received multiple prime contract...
The Department of Defense (DoD) awarded a $104,607.72 firm fixed price delivery order contract to Microgenics Corporation, a clinical diagnostics division of Thermo Electron Corporation, for the supply of drugs and biologicals. The contract is not set aside and is associated with a larger indefinite delivery vehicle held by Microgenics with the DoD. The contract supports the DoD Drug Demand Reduction Program by providing a steady supply of FDA-approved diagnostic reagents compatible with...
The Department of Veterans Affairs Veterans Health Administration has awarded a firm fixed price delivery order contract to Microgenics Corporation, a division of Thermo Electron Corporation, for the provision of drugs of abuse analyzers, reagents, and controls. The $92,603.50 contract does not have a set-aside designation and is intended to support substance abuse testing and treatment programs across VA medical facilities. Microgenics, as a prime contractor, has received multiple similar...
This is a firm fixed-price delivery order contract awarded by the Air Education and Training Command, a defense agency, to Microgenics Corporation for the manufacturing and delivery of DRI OPIATE 500ML REAGENT TEST KITS. The contract has a ceiling value of $11,388.72 and a completion date of October 16, 2025. There is no set-aside designation for this contract. Microgenics Corporation is a subsidiary of Thermo Electron Corporation and specializes in manufacturing clinical diagnostic products and...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded a $84,378 firm fixed price delivery order contract to Microgenics Corporation, Clinical Diagnostics Division for Drugs of Abuse Analyzers, Reagents, and Controls. The place of performance is Fremont, California, with work expected to be completed by September 30, 2020. Microgenics Corporation is a subsidiary of Thermo Electron Corporation, Financial Services. No set aside...
This is a firm-fixed-price Blanket Purchase Agreement (BPA) call awarded by the Veterans Integrated Service Network 1 (VISN 1) of the Department of Veterans Affairs (VA) to Microgenics Corporation, a subsidiary of Thermo Electron Corporation. The $64,162.41 contract is for the supply of toxicology reagents to support substance abuse testing and treatment programs at military medical facilities and VA hospitals. Microgenics has received over $2 million in prime contract awards from various...
  • 36C26325D0022
    Indefinite Delivery Contract
  • 36C26325D0022-36C26325N0347
    Delivery Order

This is a federal contract award to Microgenics Corporation, a clinical diagnostics division of Thermo Electron Corporation, for the supply of toxicology reagents. The contract has a ceiling value of $140,486.50 and is a delivery order under a larger indefinite delivery vehicle with the Department of Veterans Affairs (VA) Veterans Integrated Service Network 23. The contract has a period of performance through September 30, 2025 and is a firm fixed price contract. The contract supports the Department of Defense Drug Demand Reduction Program by providing a steady supply of FDA-approved diagnostic reagents compatible with clinical analyzers used in military and veteran healthcare systems. The contract has no set-aside designation, indicating Microgenics Corporation's competitive position in the federal marketplace for these types of toxicology testing products and services.

Generated 5/30/25, 10:01 AM